Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Infectious Disease In Vitro Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Infectious Disease In Vitro Diagnostics Market, by Product, 2019-2029 (USD Billion)
1.2.3. Infectious Disease In Vitro Diagnostics Market, by Application, 2019-2029 (USD Billion)
1.2.4. Infectious Disease In Vitro Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Infectious Disease In Vitro Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Infectious Disease In Vitro Diagnostics Market Dynamics
3.1. Infectious Disease In Vitro Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing geriatric population
3.1.1.2. Rising incidences of target infections
3.1.2. Market Challenges
3.1.2.1. High cost of IVD tests
3.1.3. Market Opportunities
3.1.3.1. Growing demand for PoC facilities
3.1.3.2. Increasing funding for R&D activities
Chapter 4. Global Infectious Disease In Vitro Diagnostics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Infectious Disease In Vitro Diagnostics Market, by Product
6.1. Market Snapshot
6.2. Global Infectious Disease In Vitro Diagnostics Market by Product, Performance - Potential Analysis
6.3. Global Infectious Disease In Vitro Diagnostics Market Estimates & Forecasts by Product, 2019-2029 (USD Billion)
6.4. Infectious Disease In Vitro Diagnostics Market, Sub Segment Analysis
6.4.1. Instruments
6.4.2. Reagents
6.4.3. Software
Chapter 7. Global Infectious Disease In Vitro Diagnostics Market, by Application
7.1. Market Snapshot
7.2. Global Infectious Disease In Vitro Diagnostics Market by Application, Performance - Potential Analysis
7.3. Global Infectious Disease In Vitro Diagnostics Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
7.4. Infectious Disease In Vitro Diagnostics Market, Sub Segment Analysis
7.4.1. Respiratory Virus
7.4.2. TB and Drug-resistant TB
7.4.3. Gastro-intestinal Panel Testing
7.4.4. HIV
7.4.5. Hepatitis
7.4.6. COVID-19
7.4.7. Others
Chapter 8. Global Infectious Disease In Vitro Diagnostics Market, by Technology
8.1. Market Snapshot
8.2. Global Infectious Disease In Vitro Diagnostics Market by Technology, Performance - Potential Analysis
8.3. Global Infectious Disease In Vitro Diagnostics Market Estimates & Forecasts by Technology, 2019-2029 (USD Billion)
8.4. Infectious Disease In Vitro Diagnostics Market, Sub Segment Analysis
8.4.1. Immunoassay
8.4.2. Molecular Diagnostics
8.4.3. Others
8.4.4. Microbiology
Chapter 9. Global Infectious Disease In Vitro Diagnostics Market, Regional Analysis
9.1. Infectious Disease In Vitro Diagnostics Market, Regional Market Snapshot
9.2. North America Infectious Disease In Vitro Diagnostics Market
9.2.1. U.S. Infectious Disease In Vitro Diagnostics Market
9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. Technology breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Infectious Disease In Vitro Diagnostics Market
9.3. Europe Infectious Disease In Vitro Diagnostics Market Snapshot
9.3.1. U.K. Infectious Disease In Vitro Diagnostics Market
9.3.2. Germany Infectious Disease In Vitro Diagnostics Market
9.3.3. France Infectious Disease In Vitro Diagnostics Market
9.3.4. Spain Infectious Disease In Vitro Diagnostics Market
9.3.5. Italy Infectious Disease In Vitro Diagnostics Market
9.3.6. Rest of Europe Infectious Disease In Vitro Diagnostics Market
9.4. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Snapshot
9.4.1. China Infectious Disease In Vitro Diagnostics Market
9.4.2. India Infectious Disease In Vitro Diagnostics Market
9.4.3. Japan Infectious Disease In Vitro Diagnostics Market
9.4.4. Australia Infectious Disease In Vitro Diagnostics Market
9.4.5. South Korea Infectious Disease In Vitro Diagnostics Market
9.4.6. Rest of Asia Pacific Infectious Disease In Vitro Diagnostics Market
9.5. Latin America Infectious Disease In Vitro Diagnostics Market Snapshot
9.5.1. Brazil Infectious Disease In Vitro Diagnostics Market
9.5.2. Mexico Infectious Disease In Vitro Diagnostics Market
9.6. Rest of The World Infectious Disease In Vitro Diagnostics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. QIAGEN
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. bioMerieux SA
10.2.3. F. Hoffmann-La Roche, Ltd.
10.2.4. Hologic, Inc. (Gen-Probe)
10.2.5. Abbott
10.2.6. Quidel Corp.
10.2.7. Siemens Healthineers AG
10.2.8. Bio-Rad Laboratories, Inc.
10.2.9. Danaher Corp.
10.2.10. OraSure Technologies, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption